Filana Therapeutics appoints Jill M. Quigley to board

FLNA•2026-11-11

Filana Therapeutics appointed Jill M. Quigley as an independent director. Quigley served as CEO of Genuiti Therapeutics from September 2023 through June 2025 and has more than 20 years of biotechnology leadership experience.

Filana Therapeutics appoints Jill M. Quigley to board

1. Board appointment

Related News

Swarmer shareholders approve share issuance for Ratel Robotics acquisition

ADP raises quarterly dividend to $1.90 per share

Firefly Aerospace target price raised to $54 from $40 by B. Riley

Global markets: Tech lifts world stocks as CoreWeave revives AI trade

Saudi Arabia leads further jump in OPEC+ oil output despite war